About StemCyte
StemCyte is a company based in Covina (United States) founded in 1997.. StemCyte has raised $23.25 million across 6 funding rounds from investors including unknown. The company has 43 employees as of December 31, 2022. StemCyte operates in a competitive market with competitors including China Cord Blood, Generate, LaCell, Forever Labs and Provia Labs, among others.
- Headquarter Covina, United States
- Employees 43 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Stemcyte, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.25 M (USD)
in 6 rounds
-
Latest Funding Round
$2.5 M (USD), Debt – Conventional
Nov 22, 2010
- Investors
-
Employee Count
43
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of StemCyte
StemCyte has successfully raised a total of $23.25M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $2.5 million completed in November 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Debt – Conventional — $2.5M
-
First Round
First Round
(22 Mar 2002)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2010 | Amount | Debt – Conventional - StemCyte | Valuation |
investors |
|
| Oct, 2008 | Amount | Series B - StemCyte | Valuation |
investors |
|
| Aug, 2006 | Amount | Series B - StemCyte | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in StemCyte
StemCyte has secured backing from 1 investor. Prominent investors backing the company include unknown. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by StemCyte
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - StemCyte
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Stemcyte Comparisons
Competitors of StemCyte
StemCyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as China Cord Blood, Generate, LaCell, Forever Labs and Provia Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biobanking services for umbilical cord blood stem cells are provided.
|
|
| domain | founded_year | HQ Location |
Provider of services for the storage of stem cells
|
|
| domain | founded_year | HQ Location |
Stem Cell Production
|
|
| domain | founded_year | HQ Location |
Stem cells are stored and preserved for future therapeutic applications.
|
|
| domain | founded_year | HQ Location |
Stem cell biobanking and manufacturing from children's teeth are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Stemcyte
Frequently Asked Questions about StemCyte
When was StemCyte founded?
StemCyte was founded in 1997 and raised its 1st funding round 5 years after it was founded.
Where is StemCyte located?
StemCyte is headquartered in Covina, United States. It is registered at Covina, California, United States.
Is StemCyte a funded company?
StemCyte is a funded company, having raised a total of $23.25M across 6 funding rounds to date. The company's 1st funding round was a Series B of $9.05M, raised on Mar 22, 2002.
How many employees does StemCyte have?
As of Dec 31, 2022, the latest employee count at StemCyte is 43.
What does StemCyte do?
StemCyte was founded in 1997 and focuses on umbilical cord blood stem cell transplantation and therapeutic products. Cord blood products are delivered to transplant centers for treating blood cancers, immune disorders, and genetic conditions. Storage facilities are maintained in California and Taiwan, with operations spanning the United States, India, and Taiwan. Headquarters are located in Covina, California, supporting global access to these medical resources.
Who are the top competitors of StemCyte?
StemCyte's top competitors include Forever Labs, China Cord Blood and LaCell.
Who are StemCyte's investors?
StemCyte has 1 investor. Key investors include unknown.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.